1
|
Tong Y, Dai J, Huang J, Fei X, Shen K, Liu Q, Chen X. Ki67 increase after core needle biopsy associated with worse disease outcome in HER2-negative breast cancer patients. Sci Rep 2023; 13:2489. [PMID: 36781892 PMCID: PMC9925825 DOI: 10.1038/s41598-022-25206-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2022] [Accepted: 11/28/2022] [Indexed: 02/15/2023] Open
Abstract
Ki67 would change after core needle biopsy (CNB) in invasive breast cancer. However, whether Ki67 alteration (ΔKi67) influences disease outcomes remains unclear. Here we aim to evaluate the prognostic value of ΔKi67. Patients with paired CNB and open excision biopsy (OEB) samples between January 2009 and June 2016 were retrospectively analyzed. ΔKi67 was calculated as the absolute difference between Ki67 level in CNB and OEB samples, and the median value of 5% was adopted to category patients into high- and low ΔKi67 groups. Disease-free survival (DFS) and overall survival (OS) were compared between different ΔKi67 groups. Overall, 2173 invasive breast cancer patients were included. Median Ki67 was higher in OEB than CNB samples: 25.00% versus 20.00% (P < 0.001). Axillary nodal status, STI, histological grading, and molecular subtype were independently associated with ΔKi67 (P < 0.05). In the whole population, patients with low ΔKi67 showed superior 5-year DFS (89.6% vs 87.0%, P = 0.026), but similar OS (95.8% vs 94.3%, P = 0.118) compared to those with high ΔKi67. HER2 status at surgery was the only significant factor interacting with ΔKi67 on both DFS (P = 0.026) and OS (P = 0.007). For patients with HER2-negative disease, high ΔKi67 was associated with worse 5-year DFS (87.2% vs 91.2%, P = 0.004) as well as impaired 5-year OS (93.9% vs 96.8%, P = 0.010). ΔKi67 had no significant impact on survival of HER2-positive patients. Ki67 increase after CNB was significantly associated with worse disease outcomes in HER2-negative, but not in HER2-positive patients, which warrants further study.
Collapse
Affiliation(s)
- Yiwei Tong
- Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China
| | - Jiangfeng Dai
- Department of Oncological Surgery, Shaoxing Second Hospital, Shaoxing, Zhejiang, China
| | - Jiahui Huang
- Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China
| | - Xiaochun Fei
- Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Kunwei Shen
- Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China
| | - Qingmeng Liu
- Department of Pathology, Shaoxing Second Hospital, Shaoxing, Zhejiang, China.
| | - Xiaosong Chen
- Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.
| |
Collapse
|
2
|
Karaman H, Senel F, Tasdemir A, Özer I, Dogan M. A single centre experience in Turkey for comparison between core needle biopsy and surgical specimen evaluation results for HER2, SISH, estrogen receptors and progesterone receptors in breast cancer patients. J Cancer Res Ther 2022; 18:1789-1795. [PMID: 36412445 DOI: 10.4103/jcrt.jcrt_601_20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Background Breast carcinoma diagnosis can be made with core-needle biopsy (CNB), but there are controversies regarding the evaluation of hormone receptor (HR) status in needle biopsy specimens. When preoperative neoadjuvant therapy is required in breast cancer cases, the CNB specimen should be evaluated to decide on the treatment. Objectives In this study, we aimed to compare the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and silver in situ hybridization (SISH) results of the CNB specimens and surgical specimens (SS) of our breast carcinoma cases. Materials and Methods This retrospective study included cases diagnosed with breast cancer in our center for approximately 1 year between 2017 and 2018. About 97 cases with both CNB specimens and SS were included in the study. Data such as the ER, PR, HER2, and SISH evaluation results in CNB and SS, age distribution and histopathological type, metastatic lymph nodes, lymphovascular invasion, tumor size, and grade of the tumor were recorded. The data were analyzed using SPSS 22.0 (Statistical Package for the Social Sciences, Armonk, NY, USA) software. Results All of the cases were female and 70.1% of them were aged over 45. About 27.8% of the cases were aged 31-45 years, and 2.1% were aged under 30. When evaluated according to the histopathological type of the tumor, 71.1% of cases were invasive ductal carcinoma (IDC), 8.2% were invasive lobular carcinoma (ILC), 6.2% were IDC + ILC, 11.3% were another carcinoma, and 3.1% were in situ carcinoma. 12.4% of the cases were Grade I, 43.3% were Grade II, and 20.6% were Grade III. 43.3% of our cases' tumor size were ≤2 cm and 56.7% >2 cm. 50 (51.5%) of these cases had no lymph node metastasis. It was found out that 36 (37.1%) of the cases had 1-4 metastatic lymph nodes and 11 (11.3%) of them had 5 and more metastatic lymph nodes. It was found out that 44 (45.4.%) of the cases had no lymphovascular invasion and 53 (54.6%) of them had a lymphovascular invasion. When HR statuses in CNB and SS were compared, ER was found to have a sensitivity of 96.1% and a specificity of 100%. PR was found to have a sensitivity of 94.2% and a specificity of 66.7%. HER2 was found to have a sensitivity of 100% and a specificity of 73.4%. Conclusion ER evaluation results are reliable in deciding on needle biopsy material. PR may show the heterogeneous distribution in HER2 tumor. Thus, if PR and HER2 results in needle biopsy material are negative, assessments should be repeated in SS.
Collapse
Affiliation(s)
- Hatice Karaman
- Department of Pathology, Kayseri City Training and Research Hospital, Kayseri, Turkey
| | - Fatma Senel
- Department of Pathology, Kayseri City Training and Research Hospital, Kayseri, Turkey
| | - Arzu Tasdemir
- Department of Pathology, Kayseri City Training and Research Hospital, Kayseri, Turkey
| | - Ipek Özer
- Department of Pathology, Kayseri City Training and Research Hospital, Kayseri, Turkey
| | - Merve Dogan
- Department of Pathology, Kayseri City Training and Research Hospital, Kayseri, Turkey
| |
Collapse
|
3
|
Ensani F, Omranipour R, Jahanzad I, Jafari A, Nafarzadeh S, Aminishakib P. The Core Needle and Surgical Biopsy Concordance to Detect Estrogen, Progesterone, and Her-2 Receptors in Breast Cancer: A Comparative Study. IRANIAN JOURNAL OF PATHOLOGY 2017; 12. [PMID: 29531544 PMCID: PMC5835367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
BACKGROUND &OBJECTIVES Evaluation of estrogen receptor (ER), progesterone receptor (PR), and (human epidermal growth factor receptor-2) Her-2 on core needle biopsies (CNBs) is increasingly in use to diagnosis early breast cancer, but its concordance with surgical excision (SE) is not well documented. METHODS The study included 100 formalin fixed, paraffin-embedded specimens of invasive breast carcinoma archived in Pathology Department of Cancer Institute, Tehran, Iran, from 2011 to 2014. Immunohistochemistry was applied to detect ER, PR, and Her-2. RESULTS The current study findings indicated a significant correlation of 90% between CNB and SE specimens for ER expression. The correlation between CNB and SE specimens was estimated as 81% and 97.3% for PR and Her-2, respectively. DISCUSSION CNB can be performed confidently to determine ER and Her-2. For PR, results obtained from CNB should be considered.
Collapse
Affiliation(s)
- Fereshteh Ensani
- Dept. of Pathology, Cancer Institute Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - Ramesh Omranipour
- Surgical Oncology Center Institute Hospital, Tehran University of Medical Science, Tehran, Iran
| | - Isa Jahanzad
- Dept. of Immunohistochemistry, Cancer Institute, Tehran University of Medical Science, Tehran, Iran
| | - Azadeh Jafari
- Dept. of Pathology, Cancer Institute Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - Shima Nafarzadeh
- Dept. of Oral and Maxillofacial Pathology, Babol University of Medical Sciences, Tehran, Iran,Corresponding Information: Shima Nafarzadeh, Assistant Professor, Department of Oral and Maxillofacial Pathology, Babol University of Medical Sciences, ,Tell: 0989111164609
| | - Pouyan Aminishakib
- Dept. of Oral and Maxillofacial Pathology, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
4
|
Sadoughi F, Lotfnezhad Afshar H, Olfatbakhsh A, Mehrdad N. Application of Canonical Correlation Analysis for Detecting Risk Factors Leading to Recurrence of Breast Cancer. IRANIAN RED CRESCENT MEDICAL JOURNAL 2016; 18:e23131. [PMID: 27231580 PMCID: PMC4879760 DOI: 10.5812/ircmj.23131] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/29/2014] [Revised: 10/14/2014] [Accepted: 10/22/2014] [Indexed: 01/06/2023]
Abstract
BACKGROUND Advances in treatment options of breast cancer and development of cancer research centers have necessitated the collection of many variables about breast cancer patients. Detection of important variables as predictors and outcomes among them, without applying an appropriate statistical method is a very challenging task. Because of recurrent nature of breast cancer occurring in different time intervals, there are usually more than one variable in the outcome set. For the prevention of this problem that causes multicollinearity, a statistical method named canonical correlation analysis (CCA) is a good solution. OBJECTIVES The purpose of this study was to analyze the data related to breast cancer recurrence of Iranian females using the CCA method to determine important risk factors. PATIENTS AND METHODS In this cross-sectional study, data of 584 female patients (mean age of 45.9 years) referred to Breast Cancer Research Center (Tehran, Iran) were analyzed anonymously. SPSS and NORM softwares (2.03) were used for data transformation, running and interpretation of CCA and replacing missing values, respectively. Data were obtained from Breast Cancer Research Center, Tehran, Iran. RESULTS Analysis showed seven important predictors resulting in breast cancer recurrence in different time periods. Family history and loco-regional recurrence more than 5 years after diagnosis were the most important variables among predictors and outcomes sets, respectively. CONCLUSIONS Canonical correlation analysis can be used as a useful tool for management and preparing of medical data for discovering of knowledge hidden in them.
Collapse
Affiliation(s)
- Farahnaz Sadoughi
- Department of Health Information Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, IR Iran
| | - Hadi Lotfnezhad Afshar
- Department of Health Information Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, IR Iran
- Department of Health Information Technology, School of Paramedical, Urmia University of Medical Sciences, Urmia, IR Iran
- Corresponding Author: Hadi Lotfnezhad Afshar, Department of Health Information Technology, School of Paramedical, Urmia University of Medical Sciences, Urmia, IR Iran. Tel: +98-44332752300, Fax: +98-4432770047, E-mail:
| | - Asiie Olfatbakhsh
- Breast Cancer Research Center (BCRC), The Academic Center for Education, Culture and Research (ACECR), Tehran, IR Iran
| | - Neda Mehrdad
- Breast Cancer Research Center (BCRC), The Academic Center for Education, Culture and Research (ACECR), Tehran, IR Iran
| |
Collapse
|
5
|
Liu L, Yin B, Geng DY, Lu YP, Peng WJ. Changes of T2 Relaxation Time From Neoadjuvant Chemotherapy in Breast Cancer Lesions. IRANIAN JOURNAL OF RADIOLOGY 2016; 13:e24014. [PMID: 27853488 PMCID: PMC5106820 DOI: 10.5812/iranjradiol.24014] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/28/2014] [Revised: 05/20/2015] [Accepted: 06/16/2015] [Indexed: 11/16/2022]
Abstract
Background Neoadjuvant chemotherapy (NAC) is generally an effective method of reducing locally advanced malignant breast lesions before surgery; assessing the tumor response to NAC is crucial for patient management. T2 relaxation times can reflect biological state of lesions, may prove useful to assess the response to NAC. Objectives To investigate the lesion T2 relaxation times change in breast cancer neoadjuvant chemotherapy (NAC). Patients and Methods In total, 26 patients underwent NAC. Magnetic resonance imaging (MRI) T2 mapping was performed before and after NAC. The T2 relaxation times were obtained by using Functool software on an AW 43 workstation. The treatment response was assessed according to the pathological response classification. We aimed to analyze the changes in the T2 relaxation times before and after NAC as well as to study the relationship between the response and the lesion T2 relaxation times after NAC. Results In 26 cases with NAC, the mean lesion T2 relaxation time before NAC was 81.34 ± 13.68 ms, compared with 64.50 ± 8.71 ms after NAC. Significant differences in the lesion T2 relaxation times existed between the pre- and post-NAC (P < 0.001) ; based on the pathology results, the mean lesion T2 relaxation times in 23 of the 26 responders (63.18 ± 8.37 ms) was shorter than in 3 of the 26 nonresponders (74.62 ± 2.32 ms) after NAC (P = 0.029). Conclusion In breast cancer after NAC, the lesion T2 relaxation time was reduced in the responders, and this finding is potentially useful to assess the response to NAC.
Collapse
Affiliation(s)
- Li Liu
- Department of Radiology, Shanghai Cancer Center, Fudan University, Shanghai, China
| | - Bo Yin
- Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China
| | - Dao Ying Geng
- Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China
| | - Yi Ping Lu
- Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China
| | - Wei Jun Peng
- Department of Radiology, Shanghai Cancer Center, Fudan University, Shanghai, China
- Corresponding author: Wei Jun Peng, Department of Radiology, Shanghai Cancer Center, Fudan University, Shanghai, China. Tel: +86-13817515007, E-mail:
| |
Collapse
|